Study aims: The aim of the current study was to evaluate the efficacy and safety of stepwise circumferential and focal ablation using the HALO system for Barrett’s esophagus containing flat, high-grade dysplasia (HGD) or residual dysplasia after endoscopic resection for HGD or intramucosal cancer (IMC).
Methods: Visible abnormalities were removed with endoscopic resection prior to ablation. Persistence of dysplasia and absence of IMC were confirmed with biopsy after endoscopic resection. A balloon-based electrode was used for primary circumferential ablation and an endoscope-mounted electrode was used for secondary focal ablation.
Results: Twelve patients (nine men; median age 70 years) were treated (median Barrett’s length 7 cm). Visible abnormalities were removed by endoscopic resection in seven patients. The worst pathological grade of residual Barrett’s esophagus after resection and prior to ablation was low-grade dysplasia (LGD) (n = 1) and HGD (n = 11). Patients underwent a median of one circumferential and two focal ablation sessions. Complete remission of dysplasia was achieved in 12/12 patients (100 %). Complete endoscopic and histological removal of Barrett’s esophagus was achieved in 12/12 patients (100 %). There were no ablation-related stenoses, and no subsquamous Barrett’s esophagus was observed in 363 biopsies obtained from post-ablation neo-squamous mucosa. Protocolized cleaning of the ablation zone and electrode in between ablations resulted in superior regression of Barrett’s esophagus compared with previous studies. During a median follow-up of 14 months no recurrence of dysplasia or Barrett’s esophagus was observed.
Conclusions: Stepwise circumferential and focal ablation for Barrett’s esophagus with flat HGD or for Barrett’s with residual dysplasia after endoscopic resection for HGD/IMC is a safe and effective treatment modality. Its success rate and safety profile compare favorably with alternatives such as esophagectomy, widespread endoscopic resection or photodynamic therapy.
References
-
1
Sharma V K, Wang K K, Overholt B F. et al .
Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett’s esophagus: 1-year follow-up of 100 patients.
Gastrointest Endosc.
2007;
65
185-195
-
2
Gondrie J J, Pouw R E, Sondermeijer C MT. et al .
Step-wise circumferential and focal ablation of Barrett’s esophagus with high-grade dysplasia: results of the first prospective series of 11 patients.
Endoscopy.
2008;
40
359-369
-
3
Ganz R A, Utley D S, Stern R A. et al .
Complete ablation of esophageal epithelium with a balloon-based bipolar electrode: a phased evaluation in the porcine and in the human esophagus.
Gastrointest Endosc.
2004;
60
1002-1010
-
4
Dunkin B J, Martinez J, Bejarano P A. et al .
Thin-layer ablation of human esophageal epithelium using a bipolar radiofrequency balloon device.
Surg Endosc.
2006;
20
125-130
-
5
Sharma P, Dent J, Armstrong D. et al .
The development and validation of an endoscopic grading system for Barrett’s esophagus: the Prague C & M criteria.
Gastroenterology.
2006;
131
1392-1399
-
6
Aiko T, Sasako M.
The new Japanese Classification of Gastric Carcinoma: Points to be revised.
Gastric Cancer.
1998;
1
25-30
-
7
Peters F P, Kara M A, Curvers W L. et al .
Multiband mucosectomy for endoscopic resection of Barrett’s esophagus: feasibility study with matched historical controls.
Eur J Gastroenterol Hepatol.
2007;
19
311-315
-
8
Bergman J J.
Endoscopic treatment of high-grade intraepithelial neoplasia and early cancer in Barrett’s oesophagus.
Best Pract Res Clin Gastroenterol.
2005;
19
889-907
-
9
Peters F P, Brakenhoff K PM, Curvers W L. et al .
Histological evaluation of resection specimens obtained at 293 endoscopic resections in Barrett’s esophagus.
Gastrointest Endosc.
2007;
Epub ahead of print
1-6
-
10
Ell C, May A, Pech O. et al .
Curative endoscopic resection of early esophageal adenocarcinomas (Barrett’s cancer).
Gastrointest Endosc.
2007;
65
3-10
-
11
Bergman J J.
Endoscopic resection for treatment of mucosal Barrett’s cancer: time to swing the pendulum.
Gastrointest Endosc.
2007;
65
11-13
-
12
Peters F P, Kara M A, Rosmolen W D. et al .
Endoscopic treatment of high-grade dysplasia and early stage cancer in Barrett’s esophagus.
Gastrointest Endosc.
2005;
61
506-514
-
13
May A, Gossner L, Pech O. et al .
Local endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett’s oesophagus: acute-phase and intermediate results of a new treatment approach.
Eur J Gastroenterol Hepatol.
2002;
14
1085-1091
-
14
Pech O, Gossner L, May A. et al .
Long-term results of photodynamic therapy with 5-aminolevulinic acid for superficial Barrett’s cancer and high-grade intraepithelial neoplasia.
Gastrointest Endosc.
2005;
62
24-30
-
15
Overholt B F, Lightdale C J, Wang K K. et al .
Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett’s esophagus: international, partially blinded, randomized phase III trial.
Gastrointest Endosc.
2005;
62
488-498
-
16
Prasad G A, Wang K K, Buttar N S. et al .
Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett’s esophagus.
Gastroenterology.
2007;
132
1226-1233
-
17
Ackroyd R, Brown N J, Davis M F. et al .
Photodynamic therapy for dysplastic Barrett’s oesophagus: a prospective, double blind, randomised, placebo controlled trial.
Gut.
2000;
47
612-617
-
18
Peters F, Kara M, Rosmolen W. et al .
Poor results of 5-aminolevulinic acid-photodynamic therapy for residual high-grade dysplasia and early cancer in barrett esophagus after endoscopic resection.
Endoscopy.
2005;
37
418-424
-
19
Dulai G S, Jensen D M, Cortina G. et al .
Randomized trial of argon plasma coagulation vs. multipolar electrocoagulation for ablation of Barrett’s esophagus.
Gastrointest Endosc.
2005;
61
232-240
-
20
Ackroyd R, Tam W, Schoeman M. et al .
Prospective randomized controlled trial of argon plasma coagulation ablation vs. endoscopic surveillance of patients with Barrett’s esophagus after antireflux surgery.
Gastrointest Endosc.
2004;
59
1-7
-
21
Overholt B F, Panjehpour M, Halberg D L.
Photodynamic therapy for Barrett’s esophagus with dysplasia and/or early stage carcinoma: long-term results.
Gastrointest Endosc.
2003;
58
183-188
-
22
Hornick J L, Blount P L, Sanchez C A. et al .
Biologic properties of columnar epithelium underneath reepithelialized squamous mucosa in Barrett’s esophagus.
Am J Surg Pathol.
2005;
29
372-380
-
23
Van Laethem J L, Peny M O, Salmon I. et al .
Intramucosal adenocarcinoma arising under squamous re-epithelialisation of Barrett’s oesophagus.
Gut.
2000;
46
574-577
-
24
Hage M, Siersema P D, Vissers K J. et al .
Genomic analysis of Barrett’s esophagus after ablative therapy: persistence of genetic alterations at tumor suppressor loci.
Int J Cancer.
2006;
118
155-160
-
25
Krishnadath K K, Wang K K, Taniguchi K. et al .
Persistent genetic abnormalities in Barrett’s esophagus after photodynamic therapy.
Gastroenterology.
2000;
119
624-630
-
26
Ragunath K, Krasner N, Raman V S. et al .
Endoscopic ablation of dysplastic Barrett’s oesophagus comparing argon plasma coagulation and photodynamic therapy: a randomized prospective trial assessing efficacy and cost-effectiveness.
Scand J Gastroenterol.
2005;
40
750-758
J. J. Bergman, MD
Department of Gastroenterology and Hepatology
Academic Medical Center
Meibergdreef 9
1105 AZ, Amsterdam
The Netherlands
Fax: +31-20-6917033
Email: j.j.bergman@amc.uva.nl
